Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer [Phase 3]
Phase 3 trial comparing denosumab to zoledronic acid for bone metastases in men with hormone-refractory prostate cancer completed with resul…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study [Phase 2]
The ELDORADO study is a Phase 2 trial evaluating Eligard (leuprolide acetate) with docetaxel and radiotherapy for prostate cancer; current s…
-
CLINICAL_TRIALS withdrawal · 2014-03-19Clinical Trial Update: The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation [Phase 1]
The JET Study, a Phase I trial of cabazitaxel with radiotherapy and long-term androgen deprivation for prostate cancer, has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: 11C Acetate Imaging Post Prostatectomy [NA]
This clinical trial update notes that a study evaluating 11C acetate imaging after prostatectomy for prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer [Phase 1, Phase 2]
Clinical trial update: a dose-finding study of a DNA vaccine delivered by intradermal electroporation in prostate cancer patients has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-03-17Clinical Trial Update: Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy [Phase 3]
Clinical trial update for a Phase 3 study evaluating androgen suppression combined with elective nodal radiation and dose-escalated radiothe…
-
FDA approval · 2014-03-14FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) submitted by Verity Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2014-03-14Clinical Trial Update: Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men
A completed clinical trial evaluating long-term outcomes in healthy Taiwanese men with elevated PSA, with implications for prostate cancer r…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: The Efficacy of Pilates in the Recovery of Post-prostatectomy Urinary Incontinence [NA]
A completed clinical trial evaluated whether Pilates improves recovery from urinary incontinence after prostatectomy in men with prostate ca…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]
Phase 2 trial evaluating docetaxel and prednisone with or without cediranib in metastatic prostate cancer refractory to hormone therapy; stu…
-
CLINICAL_TRIALS withdrawal · 2014-03-11Clinical Trial Update: Study of POMELLA™ Extract to Treat Prostate Cancer [NA]
A clinical trial of POMELLA™ Extract for prostate cancer has been terminated; no results are provided in this update.
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]
A Phase 2 trial of Calcitriol and Dexamethasone in hormone-refractory prostate cancer was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer [Phase 1, Phase 2]
This entry reports the completion of a Phase 1/2 clinical trial evaluating AMG 102 in combination with mitoxantrone and prednisone in men wi…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
A Phase 2 trial of a vaccine therapy combined with interleukin-12 for metastatic prostate cancer that is hormone-refractory has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of capecitabine and docetaxel for metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate [Phase 2]
A Phase 2 clinical trial evaluating soy isoflavones in prostate cancer patients undergoing radical prostatectomy has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: RAD001 and Bicalutamide for Androgen Independent Prostate Cancer [Phase 2]
Phase 2 trial evaluating everolimus (RAD001) in combination with bicalutamide for androgen-independent prostate cancer has completed with re…
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: Sulforaphane in Treating Patients With Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating sulforaphane for recurrent prostate cancer has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluated the combination of everolimus (RAD001) with docetaxel in metastatic castration-resistant prostate cancer; the tr…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients [Phase 2]
Phase 2 clinical trial evaluating toxicity and efficacy of lenalidomide (Revlimid) in chemotherapy-naïve androgen-independent prostate cance…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer [Phase 2]
Phase 2 trial of high-dose silybin-phytosome in men with prostate cancer has completed. Results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Guided Biopsy for Mapping Prostate Cancer [NA]
A clinical trial investigating guided biopsy for mapping prostate cancer sponsored by Roswell Park Cancer Institute has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 3]
This document reports the completed Phase 3 trial S9916 evaluating the combination of docetaxel and estramustine in men with advanced prosta…
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer [NA]
This clinical trial update discusses the use of CyberKnife stereotactic radiosurgery for patients with low- and intermediate-risk prostate c…
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Perioperative Electroacupuncture on Postoperative Analgesia in Prostatectomy [Phase 4]
A Phase 4 trial assessing whether perioperative electroacupuncture improves postoperative analgesia after prostatectomy has completed.